NCT00992563View on ClinicalTrials.gov

WALTZ - Wet Age-Related Macular Degeneration (AMD) AL-39324 Treatment Examination

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

May 31, 2011

Conditions
Age Related Macular Degeneration
Interventions
DRUG

AL-39324 ophthalmic suspension

DRUG

Ranibizumab 10 mg/mL

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY